Clinical Trial: EO4010 in Previously Treated Metastatic Colorectal Carcinoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Colorectal Cancer Metastatic
Study Type: INTERVENTIONAL
Official Title: A Global Multicenter Phase 1/2 Trial of EO4010, a Novel Microbial Derived Peptide Therapeutic Vaccine, in Combination With Nivolumab, for Treatment of Patients With Previously Treated Metastatic
Brief Summary:
Open-label multicenter study
Read more